Monideepa Roy

Monideepa Roy

Company: Actinium Pharmaceuticals

Job title: Vice President - Corporate, Research & Development

Seminars:

Leveraging the Power of Targeted Radiotherapy to Build a Pipeline of Highly Differentiated Radiotherapeutics for Conditioning, Heme & Solid Tumor Malignancies 1:30 pm

• Leading specialty oncology radiotherapeutics company with a Ph III-complete, paradigm shifting induction and conditioning agent, Iomab-B for R/R AML and a robust pipeline of both heme and solid tumor opportunities leveraging a 160-patent backed proprietary platform • Actimab-A investigated in R/R AML trials including in combination with Bcl-2 targeted venetoclax and the salvage chemotherapy…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.